WallStreetZenWallStreetZen

NASDAQ: LGND
Ligand Pharmaceuticals Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Ligand Pharmaceuticals revenue was $167.13M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $42.8M, down 17.4% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LGND annual revenue was $167.1M, with 27.3% growth year-over-year.

LGND past revenue growth

How has LGND's revenue growth performed historically?

Company
27.28%
Industry
497.69%
Market
20.68%
LGND's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
LGND's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
LGND's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

LGND revenue history

Current Revenue
$167.1M
Current Earnings
-$4.0M
Current Profit Margin
-2.4%

Be the first to know when LGND announces revenue.

LGND Revenue History By Year

LGND Yearly RevenueLGND RevenueLGND ChangeLGND Revenue Growth
2024-12-31$167.13M$35.82M+27.28%
2023-12-31$131.31M-$64.93M-33.09%
2022-12-31$196.25M-$45.30M-18.75%
2021-12-31$241.54M$77.98M+47.68%
2020-12-31$163.56M$43.28M+35.98%
2019-12-31$120.28M-$131.17M-52.17%
2018-12-31$251.45M$110.35M+78.21%
2017-12-31$141.10M$32.13M+29.48%
2016-12-31$108.97M$37.06M+51.53%
2015-12-31$71.91M$7.38M+11.43%
2014-12-31$64.54M$15.57M+31.78%
2013-12-31$48.97M$17.59M+56.02%
2012-12-31$31.39M$1.35M+4.50%
2011-12-31$30.04M$6.50M+27.61%
2010-12-31$23.54M-$15.40M-39.55%
2009-12-31$38.94M$11.63M+42.56%
2008-12-31$27.32M$14.42M+111.84%
2007-12-31$12.89M$8.92M+224.21%
2006-12-31$3.98M-$6.24M-61.07%
2005-12-31$10.22M-$101.90M-90.89%
2004-12-31$112.11M$30.99M+38.21%
2003-12-31$81.12M$9.35M+13.03%
2002-12-31$71.77M-$4.57M-5.99%
2001-12-31$76.34M$28.23M+58.68%
2000-12-31$48.11M$7.22M+17.64%
1999-12-31$40.90M$23.22M+131.40%
1998-12-31$17.67M-$34.03M-65.82%
1997-12-31$51.70M$14.86M+40.33%
1996-12-31$36.84M$12.33M+50.28%
1995-12-31$24.52M$11.21M+84.21%
1994-12-31$13.31MN/AN/A

1 of 3

Ligand Pharmaceuticals Revenue FAQ

What was LGND's revenue last quarter?

On Invalid Date, Ligand Pharmaceuticals (NASDAQ: LGND) reported Q4 2024 revenue of $42.81 million up 52.35% year over year. In the same quarter last year, Ligand Pharmaceuticals's revenue was $28.10 million.

What was Ligand Pharmaceuticals's revenue in 2024?

Ligand Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $167.13 million, a 27.28% increase year over year.

How much does Ligand Pharmaceuticals make in a day?

Based on Ligand Pharmaceuticals annual revenue for the past five years, LGND makes an average of $493,040.00 per day.

What was Ligand Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Ligand Pharmaceuticals's revenue has grown 27.28% year over year. This is 470.42 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Ligand Pharmaceuticals's revenue in the past year totaled $167.13 million.

How much does Ligand Pharmaceuticals make in a year?

Ligand Pharmaceuticals's revenue by year for the past five years is:
  • Ligand Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $167.13 million, a 27.28% increase year over year.
  • Ligand Pharmaceuticals's annual revenue for Dec 31, 2023 was $131.31 million, a 33.09% decrease from 2022.
  • Ligand Pharmaceuticals's annual revenue for 2022 was $196.25 million, a 18.75% decrease from 2021.
  • Ligand Pharmaceuticals's annual revenue for 2021 was $241.54 million, a 47.68% increase from 2020.
  • Ligand Pharmaceuticals's annual revenue for 2020 was $163.56 million, a 35.98% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.